EAMA
ALNY icon

EFG Asset Management (Americas)’s Alnylam Pharmaceuticals ALNY Stock Holding History

EFG Asset Management (Americas)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.44M Sell
9,738
-1,877
-16% -$764K 0.77% 42
2025
Q2 		$3.79M Sell
11,615
-1,757
-13% -$486K 0.7% 46
2025
Q1 		$3.61M Sell
13,372
-1,574
-11% -$405K 0.73% 46
2024
Q4 		$3.52M Sell
14,946
-7
-0% -$1.84K 0.68% 51
2024
Q3 		$4.11M Sell
14,953
-2,039
-12% -$531K 0.8% 43
2024
Q2 		$4.13M Buy
16,992
+6,106
+56% +$964K 0.81% 42
2024
Q1 		$1.63M Sell
10,886
-5,365
-33% -$895K 0.5% 61
2023
Q4 		$3.11M Buy
16,251
+794
+5% +$135K 0.67% 46
2023
Q3 		$2.74M Sell
15,457
-278
-2% -$53K 0.66% 49
2023
Q2 		$2.99M Buy
15,735
+556
+4% +$110K 0.69% 45
2023
Q1 		$3.04M Sell
15,179
-238
-2% -$50K 0.73% 45
2022
Q4 		$3.66M Buy
15,417
+275
+2% +$58.7K 0.91% 35
2022
Q3 		$3.03M Buy
15,142
+1,893
+14% +$361K 0.77% 44
2022
Q2 		$1.93M Sell
13,249
-3,489
-21% -$495K 0.46% 59
2022
Q1 		$2.73M Buy
+16,738
New +$2.55M 0.51% 55
2021
Q3 		– Sell
-26,187
Closed -$4.44M – 136
2021
Q2 		$4.44M Buy
26,187
+1,747
+7% +$256K 0.82% 44
2021
Q1 		$3.45M Buy
24,440
+1,020
+4% +$153K 0.71% 52
2020
Q4 		$3.04M Buy
23,420
+2,341
+11% +$313K 0.62% 58
2020
Q3 		$3.07M Buy
+21,079
New +$3M 0.69% 57

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

EFG Asset Management (Americas)'s ALNY Position: Q3 2025 in Review

EFG Asset Management (Americas) reduced its Alnylam Pharmaceuticals (ALNY) stake by 16% in Q3 2025, selling an estimated $764K and leaving 9,738 shares worth $4.44M. The position accounts for 0.77% of the portfolio, ranked #42.

EFG Asset Management (Americas) first reported a position in ALNY in Q3 2020 and has held it in 19 quarters since. 823 funds tracked by Wall St. Rank hold ALNY as of Q3 2025.

  • EFG Asset Management (Americas) held 9,738 shares of Alnylam Pharmaceuticals worth $4.44M as of Q3 2025.
  • EFG Asset Management (Americas) sold 1,877 Alnylam Pharmaceuticals shares in Q3 2025, an estimated $764K.
  • Alnylam Pharmaceuticals made up 0.77% of EFG Asset Management (Americas)'s portfolio in Q3 2025, its #42 holding.
  • EFG Asset Management (Americas) first reported a position in Alnylam Pharmaceuticals in Q3 2020 and has held it in 19 quarters since.
  • 823 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2025.

Based on EFG Asset Management (Americas)'s 13F filing for Q3 2025, filed 14 Nov 2025.